Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 380

1.

A systematic review of patient reported outcome measures for women with macromastia who have undergone breast reduction surgery.

Lonie S, Sachs R, Shen A, Hunter-Smith DJ, Rozen WM, Seifman M.

Gland Surg. 2019 Aug;8(4):431-440. doi: 10.21037/gs.2019.03.08. Review.

2.

Addressing Pharmaceutical Price Spikes Through Generic Preclearance.

Sachs RE.

J Leg Med. 2019 Apr-Jun;39(2):169-176. doi: 10.1080/01947648.2019.1645543. No abstract available.

PMID:
31503530
3.

Evaluating New Rules on Transparency in Cancer Research and Drug Development.

Hwang TJ, Vokinger KN, Sachs RE.

JAMA Oncol. 2019 Apr 1;5(4):461-462. doi: 10.1001/jamaoncol.2018.7093. No abstract available.

PMID:
30789629
4.

Synergy theory for murine Harderian gland tumours after irradiation by mixtures of high-energy ionized atomic nuclei.

Huang EG, Lin Y, Ebert M, Ham DW, Zhang CY, Sachs RK.

Radiat Environ Biophys. 2019 May;58(2):151-166. doi: 10.1007/s00411-018-00774-x. Epub 2019 Feb 2.

5.

A Smarter Way to Provide Epinephrine at School.

Frakt A, Sachs R.

JAMA Pediatr. 2019 Feb 1;173(2):130-132. doi: 10.1001/jamapediatrics.2018.4540. No abstract available.

PMID:
30575853
6.

Hypo-fractionated boost in locally advanced non-small cell lung cancer: temporal distribution of boost fractions.

Fakir H, Chen J, Sachs RK.

Phys Med Biol. 2018 Nov 28;63(23):235018. doi: 10.1088/1361-6560/aaee24.

PMID:
30484435
7.

Expansion of the Medicare 340B Payment Program: Hospital Participation, Prescribing Patterns and Reimbursement, and Legal Challenges.

Bach PB, Sachs RE.

JAMA. 2018 Dec 11;320(22):2311-2312. doi: 10.1001/jama.2018.15667. No abstract available.

PMID:
30453324
8.

Limiting State Flexibility in Drug Pricing.

Bagley N, Sachs RE.

N Engl J Med. 2018 Sep 13;379(11):1002-1004. doi: 10.1056/NEJMp1809358. No abstract available.

PMID:
30207910
9.

Synergy Theory in Radiobiology.

Ham DW, Song B, Gao J, Yu J, Sachs RK.

Radiat Res. 2018 Mar;189(3):225-237. doi: 10.1667/RR14948.1. Epub 2017 Dec 29.

PMID:
29286257
10.

Encouraging New Uses for Old Drugs.

Sachs RE, Ginsburg PB, Goldman DP.

JAMA. 2017 Dec 26;318(24):2421-2422. doi: 10.1001/jama.2017.17535. No abstract available.

PMID:
29204602
11.

Innovative Contracting for Pharmaceuticals and Medicaid's Best-Price Rule.

Sachs R, Bagley N, Lakdawalla DN.

J Health Polit Policy Law. 2018 Feb 1;43(1):5-18. doi: 10.1215/03616878-4249796.

PMID:
28972020
12.

An FDA Commissioner for the 21st Century.

Chandra A, Sachs RE.

N Engl J Med. 2017 Apr 13;376(15):e31. doi: 10.1056/NEJMp1703979. Epub 2017 Mar 29. No abstract available.

PMID:
28402241
13.

Scaling Human Cancer Risks from Low LET to High LET when Dose-Effect Relationships are Complex.

Shuryak I, Fornace AJ Jr, Datta K, Suman S, Kumar S, Sachs RK, Brenner DJ.

Radiat Res. 2017 Apr;187(4):476-482. doi: 10.1667/RR009CC.1. Epub 2017 Feb 20.

PMID:
28218889
14.

Mixed Beam Murine Harderian Gland Tumorigenesis: Predicted Dose-Effect Relationships if neither Synergism nor Antagonism Occurs.

Siranart N, Blakely EA, Cheng A, Handa N, Sachs RK.

Radiat Res. 2016 Dec;186(6):577-591. doi: 10.1667/RR14411.1. Epub 2016 Nov 22.

PMID:
27874325
15.

Innovation-Innovation Tradeoffs in Drug Pricing.

Sachs RE, Frakt AB.

Ann Intern Med. 2016 Dec 20;165(12):871-872. doi: 10.7326/M16-2167. Epub 2016 Oct 11. No abstract available.

PMID:
27723887
16.

Inhibition of Aβ(1-40) fibril formation by cyclophilins.

Villmow M, Baumann M, Malesevic M, Sachs R, Hause G, Fändrich M, Balbach J, Schiene-Fischer C.

Biochem J. 2016 May 15;473(10):1355-68. doi: 10.1042/BCJ20160098. Epub 2016 Mar 18.

PMID:
26994210
17.

Ionizing radiation exposures in treatments of solid neoplasms are not associated with subsequent increased risks of chronic lymphocytic leukemia.

Radivoyevitch T, Sachs RK, Gale RP, Smith MR, Hill BT.

Leuk Res. 2016 Apr;43:9-12. doi: 10.1016/j.leukres.2016.02.008. Epub 2016 Feb 21.

PMID:
26922774
18.

Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation.

Radivoyevitch T, Sachs RK, Gale RP, Molenaar RJ, Brenner DJ, Hill BT, Kalaycio ME, Carraway HE, Mukherjee S, Sekeres MA, Maciejewski JP.

Leukemia. 2016 Feb;30(2):285-94. doi: 10.1038/leu.2015.258. Epub 2015 Sep 22.

PMID:
26460209
19.

Ensuring the safe and effective FDA regulation of fecal microbiota transplantation.

Sachs RE, Edelstein CA.

J Law Biosci. 2015 Jul 6;2(2):396-415. eCollection 2015 Jul.

20.

Thinking Concretely Increases the Perceived Likelihood of Risks: The Effect of Construal Level on Risk Estimation.

Lermer E, Streicher B, Sachs R, Raue M, Frey D.

Risk Anal. 2016 Mar;36(3):623-37. doi: 10.1111/risa.12445. Epub 2015 Jun 26.

PMID:
26111548
21.

Suggested posthypnotic amnesia in psychiatric patients and normals.

Frischholz EJ, Lipman LS, Braun BG, Sachs R.

Am J Clin Hypn. 2015;57(2):110-21. doi: 10.1080/00029157.2015.967059.

PMID:
25928596
22.

Construct Validity of the Dissociative Experiences Scale: II. Its Relationship to Hypnotizability.

Frischholz EJ, Braun BG, Sachs RG, Schwartz DR, Lewis J, Shaeffer D, Westergaard C, Pasquotto J.

Am J Clin Hypn. 2015;57(2):102-9. doi: 10.1080/00029157.2015.967056.

PMID:
25928595
23.

Biological effects of proton radiation: an update.

Girdhani S, Sachs R, Hlatky L.

Radiat Prot Dosimetry. 2015 Sep;166(1-4):334-8. doi: 10.1093/rpd/ncv178. Epub 2015 Apr 20.

PMID:
25897135
24.

Stochastic process pharmacodynamics: dose timing in neonatal gentamicin therapy as an example.

Radivoyevitch T, Siranart N, Hlatky L, Sachs R.

AAPS J. 2015 Mar;17(2):447-56. doi: 10.1208/s12248-014-9715-3. Epub 2015 Feb 7.

25.

Proximity-induced ferromagnetism in graphene revealed by the anomalous Hall effect.

Wang Z, Tang C, Sachs R, Barlas Y, Shi J.

Phys Rev Lett. 2015 Jan 9;114(1):016603. Epub 2015 Jan 7.

PMID:
25615490
26.

Etiology and treatment of hematological neoplasms: stochastic mathematical models.

Radivoyevitch T, Li H, Sachs RK.

Adv Exp Med Biol. 2014;844:317-46. doi: 10.1007/978-1-4939-2095-2_16. Review.

PMID:
25480649
27.

Why is there so much therapy-related AML and MDS and so little therapy-related CML?

Gale RP, Hlatky L, Sachs RK, Radivoyevitch T.

Leuk Res. 2014 Oct;38(10):1162-4. doi: 10.1016/j.leukres.2014.08.002. Epub 2014 Aug 11. No abstract available.

PMID:
25175829
28.

Ferroelectric-like SrTiO3 surface dipoles probed by graphene.

Sachs R, Lin Z, Shi J.

Sci Rep. 2014 Jan 13;4:3657. doi: 10.1038/srep03657.

29.

Sex differences in the incidence of chronic myeloid leukemia.

Radivoyevitch T, Jankovic GM, Tiu RV, Saunthararajah Y, Jackson RC, Hlatky LR, Gale RP, Sachs RK.

Radiat Environ Biophys. 2014 Mar;53(1):55-63. doi: 10.1007/s00411-013-0507-4. Epub 2013 Dec 13.

30.

Repopulation of interacting tumor cells during fractionated radiotherapy: stochastic modeling of the tumor control probability.

Fakir H, Hlatky L, Li H, Sachs R.

Med Phys. 2013 Dec;40(12):121716. doi: 10.1118/1.4829495.

31.

Biological effects of proton radiation: what we know and don't know.

Girdhani S, Sachs R, Hlatky L.

Radiat Res. 2013 Mar;179(3):257-72. doi: 10.1667/RR2839.1. Epub 2013 Feb 1. Review.

PMID:
23373900
32.

Age and space irradiation modulate tumor progression: implications for carcinogenesis risk.

Beheshti A, Sachs RK, Peluso M, Rietman E, Hahnfeldt P, Hlatky L.

Radiat Res. 2013 Feb;179(2):208-20. doi: 10.1667/RR3100.1. Epub 2013 Jan 4.

PMID:
23289386
33.

Radiation-induced cancer: a modern view.

Shah DJ, Sachs RK, Wilson DJ.

Br J Radiol. 2012 Dec;85(1020):e1166-73. doi: 10.1259/bjr/25026140. Review.

34.

Smoking cessation interventions in the pre-admission clinic: assessing two approaches.

Sachs R, Wild TC, Thomas L, Hammal F, Finegan BA.

Can J Anaesth. 2012 Jul;59(7):662-9. doi: 10.1007/s12630-012-9716-6. Epub 2012 Apr 28.

PMID:
22544475
35.

We forget at our peril the lessons built into the α/β model.

Brenner DJ, Sachs RK, Peters LJ, Withers HR, Hall EJ.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1312-4. doi: 10.1016/j.ijrobp.2011.12.045. No abstract available.

PMID:
22385706
36.

Quantitative modeling of chronic myeloid leukemia: insights from radiobiology.

Radivoyevitch T, Hlatky L, Landaw J, Sachs RK.

Blood. 2012 May 10;119(19):4363-71. doi: 10.1182/blood-2011-09-381855. Epub 2012 Feb 21. Review.

37.

Learning new vocabulary in German: the effects of inferring word meanings, type of feedback, and time of test.

Carpenter SK, Sachs RE, Martin B, Schmidt K, Looft R.

Psychon Bull Rev. 2012 Feb;19(1):81-6. doi: 10.3758/s13423-011-0185-7.

PMID:
22135107
38.

RNA single strands bind to a conserved surface of the major cold shock protein in crystals and solution.

Sachs R, Max KE, Heinemann U, Balbach J.

RNA. 2012 Jan;18(1):65-76. doi: 10.1261/rna.02809212. Epub 2011 Nov 29.

39.

A multicellular basis for the origination of blast crisis in chronic myeloid leukemia.

Sachs RK, Johnsson K, Hahnfeldt P, Luo J, Chen A, Hlatky L.

Cancer Res. 2011 Apr 15;71(8):2838-47. doi: 10.1158/0008-5472.CAN-10-4600. Epub 2011 Apr 12.

40.

A new view of radiation-induced cancer.

Shuryak I, Sachs RK, Brenner DJ.

Radiat Prot Dosimetry. 2011 Feb;143(2-4):358-64. doi: 10.1093/rpd/ncq389. Epub 2010 Nov 27.

41.

Cancer risks after radiation exposure in middle age.

Shuryak I, Sachs RK, Brenner DJ.

J Natl Cancer Inst. 2010 Nov 3;102(21):1628-36. doi: 10.1093/jnci/djq346. Epub 2010 Oct 25.

42.

The balance between initiation and promotion in radiation-induced murine carcinogenesis.

Shuryak I, Ullrich RL, Sachs RK, Brenner DJ.

Radiat Res. 2010 Sep;174(3):357-66. doi: 10.1667/RR2143.1.

43.

Modeling progression in radiation-induced lung adenocarcinomas.

Fakir H, Hofmann W, Sachs RK.

Radiat Environ Biophys. 2010 May;49(2):169-76. doi: 10.1007/s00411-009-0264-6. Epub 2010 Jan 8.

44.

A rapid-mutation approximation for cell population dynamics.

Sachs RK, Hlatky L.

Bull Math Biol. 2010 Feb;72(2):359-74. doi: 10.1007/s11538-009-9450-6. Epub 2009 Dec 30.

PMID:
20041355
45.

Stochastic population dynamic effects for lung cancer progression.

Fakir H, Tan WY, Hlatky L, Hahnfeldt P, Sachs RK.

Radiat Res. 2009 Sep;172(3):383-93. doi: 10.1667/RR1621.1.

PMID:
19708787
46.

A new view of radiation-induced cancer: integrating short- and long-term processes. Part I: approach.

Shuryak I, Hahnfeldt P, Hlatky L, Sachs RK, Brenner DJ.

Radiat Environ Biophys. 2009 Aug;48(3):263-74. doi: 10.1007/s00411-009-0230-3. Epub 2009 Jun 18. Erratum in: Radiat Environ Biophys. 2011 Nov;50(4):607-8.

47.

A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation.

Shuryak I, Hahnfeldt P, Hlatky L, Sachs RK, Brenner DJ.

Radiat Environ Biophys. 2009 Aug;48(3):275-86. doi: 10.1007/s00411-009-0231-2. Epub 2009 Jun 5. Erratum in: Radiat Environ Biophys. 2011 Nov;50(4):607-8.

48.

Triggering-response model for radiation-induced bystander effects.

Fakir H, Hofmann W, Tan WY, Sachs RK.

Radiat Res. 2009 Mar;171(3):320-31. doi: 10.1667/RR1293.1.

PMID:
19267559
49.

Cancer-causing karyotypes: chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function.

Li L, McCormack AA, Nicholson JM, Fabarius A, Hehlmann R, Sachs RK, Duesberg PH.

Cancer Genet Cytogenet. 2009 Jan 1;188(1):1-25. doi: 10.1016/j.cancergencyto.2008.08.016.

PMID:
19061776
50.

B-type natriuretic peptide, a marker of asymptomatic left ventricular dysfunction in type 2 diabetic patients.

Albertini JP, Cohen R, Valensi P, Sachs RN, Charniot JC.

Diabetes Metab. 2008 Sep;34(4 Pt 1):355-62. doi: 10.1016/j.diabet.2008.02.004. Epub 2008 Jul 2.

PMID:
18599336

Supplemental Content

Support Center